ADJUVANT CAPECITABINE: A NEW STANDARD OF CARE IN BILIARY TRACT CANCER

被引：3
作者：
Lamarca, Angela [1 ]
Gambardella, Valentina [2 ]
Cejalvo, Juan-Miguel [2 ]
Fleitas-Kanonnikoff, Tania [2 ]
Cervantes, Andres [2 ]
机构：
[1] Univ Manchester, Div Canc Sci, Dept Med Oncol, Manchester, Lancs, England
[2] Univ Valencia, Biomed Res Inst INCLIVA, Dept Med Oncol, CiberOnc, Valencia, Spain
来源：
ESMO OPEN | 2019年 / 4卷 / 03期
关键词：
GEMCITABINE; CHOLANGIOCARCINOMA; CHEMOTHERAPY; THERAPY;
D O I：
10.1136/esmoopen-2019-000547
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 16 条
  • [1] WRN helicase is a synthetic lethal target in microsatellite unstable cancers
    Chan, Edmond M.
    Shibue, Tsukasa
    McFarland, James M.
    Gaeta, Benjamin
    Ghandi, Mahmoud
    Dumont, Nancy
    Gonzalez, Alfredo
    McPartlan, Justine S.
    Li, Tianxia
    Zhang, Yanxi
    Liu, Jie Bin
    Lazaro, Jean-Bernard
    Gu, Peili
    Piett, Cortt G.
    Apffel, Annie
    Ali, Syed O.
    Deasy, Rebecca
    Keskula, Paula
    Ng, Raymond W. S.
    Roberts, Emma A.
    Reznichenko, Elizaveta
    Leung, Lisa
    Alimova, Maria
    Schenone, Monica
    Islam, Mirazul
    Maruvka, Yosef E.
    Liu, Yang
    Roper, Jatin
    Raghavan, Srivatsan
    Giannakis, Marios
    Tseng, Yuen-Yi
    Nagel, Zachary D.
    D'Andrea, Alan
    Root, David E.
    Boehm, Jesse S.
    Getz, Gad
    Chang, Sandy
    Golub, Todd R.
    Tsherniak, Aviad
    Vazquez, Francisca
    Bass, Adam J.
    [J]. NATURE, 2019, 568 (7753) : 551 - +
  • [2] Cholangiocarcinoma - Thirty-one-year experience with 564 patients at a single institution
    DeOliveira, Michelle L.
    Cunningham, Steven C.
    Cameron, John L.
    Kamangar, Farin
    Winter, Jordan M.
    Lillemoe, Keith D.
    Choti, Michael C.
    Yeo, Charles J.
    Schulick, Richard D.
    [J]. ANNALS OF SURGERY, 2007, 245 (05) : 755 - 762
  • [3] Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer
    Ebata, T.
    Hirano, S.
    Konishi, M.
    Uesaka, K.
    Tsuchiya, Y.
    Ohtsuka, M.
    Kaneoka, Y.
    Yamamoto, M.
    Ambo, Y.
    Shimizu, Y.
    Ozawa, F.
    Fukutomi, A.
    Ando, M.
    Nimura, Y.
    Nagino, M.
    [J]. BRITISH JOURNAL OF SURGERY, 2018, 105 (03) : 192 - 202
  • [4] Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study
    Edeline, Julien
    Benabdelghani, Meher
    Bertaut, Aurelie
    Watelet, Jerome
    Hammel, Pascal
    Joly, Jean-Paul
    Boudjema, Karim
    Fartoux, Laetitia
    Bouhier-Leporrier, Karine
    Jouve, Jean-Louis
    Faroux, Roger
    Guerin-Meyer, Veronique
    Kurtz, Jean-Emmanuel
    Assenat, Eric
    Seitz, Jean-Francois
    Baumgaertner, Isabelle
    Tougeron, David
    de la Fouchardiere, Christelle
    Lombard-Bohas, Catherine
    Boucher, Eveline
    Stanbury, Trevor
    Louvet, Christophe
    Malka, David
    Phelip, Jean-Marc
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08) : 658 - +
  • [5] Adjuvant Therapy in the Treatment of Biliary Tract Cancer: A Systematic Review and Meta-Analysis
    Horgan, Anne M.
    Amir, Eitan
    Walter, Thomas
    Knox, Jennifer J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (16) : 1934 - 1940
  • [6] The Landscape of Microsatellite Instability in Colorectal and Endometrial Cancer Genomes
    Kim, Tae-Min
    Laird, Peter W.
    Park, Peter J.
    [J]. CELL, 2013, 155 (04) : 858 - 868
  • [7] Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
    Le, Dung T.
    Durham, Jennifer N.
    Smith, Kellie N.
    Wang, Hao
    Bartlett, Bjarne R.
    Aulakh, Laveet K.
    Lu, Steve
    Kemberling, Holly
    Wilt, Cara
    Luber, Brandon S.
    Wong, Fay
    Azad, Nilofer S.
    Rucki, Agnieszka A.
    Laheru, Dan
    Donehower, Ross
    Zaheer, Atif
    Fisher, George A.
    Crocenzi, Todd S.
    Lee, James J.
    Greten, Tim F.
    Duffy, Austin G.
    Ciombor, Kristen K.
    Eyring, Aleksandra D.
    Lam, Bao H.
    Joe, Andrew
    Kang, S. Peter
    Holdhoff, Matthias
    Danilova, Ludmila
    Cope, Leslie
    Meyer, Christian
    Zhou, Shibin
    Goldberg, Richard M.
    Armstrong, Deborah K.
    Bever, Katherine M.
    Fader, Amanda N.
    Taube, Janis
    Housseau, Franck
    Spetzler, David
    Xiao, Nianqing
    Pardoll, Drew M.
    Papadopoulos, Nickolas
    Kinzler, Kenneth W.
    Eshleman, James R.
    Vogelstein, Bert
    Anders, Robert A.
    Diaz, Luis A., Jr.
    [J]. SCIENCE, 2017, 357 (6349) : 409 - 413
  • [8] Adjuvant capecitabine in biliary tract cancer: a standard option?
    Malka, David
    Edeline, Julien
    [J]. LANCET ONCOLOGY, 2019, 20 (05) : 606 - 608
  • [9] Pantelidou C., 2019, CANC DISCOV
  • [10] Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
    Primrose, John N.
    Fox, Richard P.
    Palmer, Daniel H.
    Malik, Hassan Z.
    Prasad, Raj
    Mirza, Darius
    Anthony, Alan
    Corrie, Pippa
    Falk, Stephen
    Finch-Jones, Meg
    Wasan, Harpreet
    Ross, Paul
    Wall, Lucy
    Wadsley, Jonathan
    Evans, Jeff T. R.
    Stocken, Deborah
    Praseedom, Raaj
    Ma, Yuk Ting
    Davidson, Brian
    Neoptolemos, John P.
    Iveson, Tim
    Raftery, James
    Zhu, Shihua
    Cunningham, David
    Garden, O. James
    Stubbs, Clive
    Valle, Juan W.
    Bridgewater, John
    [J]. LANCET ONCOLOGY, 2019, 20 (05) : 663 - 673
12